Hemodialysis Adequacy - PowerPoint PPT Presentation

slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Hemodialysis Adequacy PowerPoint Presentation
Download Presentation
Hemodialysis Adequacy

play fullscreen
1 / 60
Hemodialysis Adequacy
603 Views
Download Presentation
arin
Download Presentation

Hemodialysis Adequacy

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Hemodialysis Adequacy Lutfi Alkorbi MD King Faisal Specialist Hospital Riyadh Saudi Arabia

  2. Global dialysis population

  3. Cardiovascular mortality in general population VS ESRD patients

  4. Mortality in Hemodialysis Patients in Europe, Japan, and the United States DOPPS 2006

  5. Dialysis adequacy and death The effect of dialysis dose on survival

  6. First Randomised Controlled Trial In Dialysis • The National Cooperative Dialysis Study (NCDS) was the first multicentric, randomized and controlled trial to investigate the impact of dialysis dose on patients' outcome. 160 patients were randomized to two different urea time‐averaged concentrations (TAC; 100 vs 50 mg/dl) and to two different treatment times (2.5–3.5 vs 4.5–5.5 h) and followed‐up for 6 months. NCDS 1980

  7. First Randomised Controlled Trial In Dialysis Predialysis urea 38 vs 26 mmol. Dialysis 2.5-35h vs 4.5-5 h high kt/v and long dialysis high kt/v and short dialysis low kt/v and long dialysis low kt/v and short dialysis NCDS 1980

  8. Secondary analysis of NCDS • A quantification of dialysis dose using spKt/V was first proposed by Gotch in a secondary analysis of NCDS data. In his analysis, probability of dialysis failure was higher for Kt/V ≤0.8 and abruptly decreased for Kt/V >0.9.

  9. Higher Kt/V has better outcome Kt/v=1.2 GotchFA,Sargent Kidney Int 1985;28:526

  10. NCDS Conclusion • Thus, according to NCDS patient morbidity and treatment failure are related to the dialysis dose

  11. Why Should We Measure Dialysis Dose? • There is a correlation between delivered dose of hemodialysis and patient morbidity and mortality • Clinical symptoms are not reliable

  12. Increasing dialysis dose improved survival dialysis dose Kidney Int 1996; 50:550

  13. Measures of dialysis adequacy • SpKt/V • eKt/V • StdKt/V • URR

  14. Hemodialysis Dose Measurement • Kt/V K= dialyzer urea clearance L/h t = dialysis session length hr v = distribution volume of urea L • URR

  15. Urea reduction Ratio(URR) URR = 100 x (1-Ct/Co) Ct = postdialysis BUN Co = predialysis BUN

  16. Urea Reduction Volume (URR) • Simple • Prediction of mortality Limitation: Does not account for the contribution of UF to dialysis dose Kt/V=1.1 (UF=0) Kt/v = 1.35 (UF=10%BW) URR=65

  17. URR & Kt/V

  18. Hemodialysis Dose Measurement • The preferred method is by formal kinetic urea modeling K/DOQI 2006

  19. Kt/V Computerized software Mathematical logarithm Kt/v = -Ln (R-0.008t)+(4-3.5xR) x UF W Ln = natural logarithm R = postdialysis BUN predialysis BUN UF = Ultrafiltration volume in liters W = Postdialysis weight in kg

  20. BUN Sampling • Predialysis • Postdialysis • Immediate predialysis • Slow flow/stop pump

  21. Urea Rebound • Organs with low blood flow (skin, bone, muscles) may serve as reservoir for urea 70% of TBW is contained in organs that receive only 20% of CO So: during HD, there is loss of urea from well perfused areas, this result in  in BUN over 60 minutes post dialysis.

  22. Post Dialysis BUN Sampling Avoid 2 rebound: Early (<3min post dialysis) • Access recirculation,begin immediately post hemodialysis and rebound in 20 seconds • Cardiopulmonary recirculation, begin 20 seconds post hemodialysis and is completed in 2-3 minutes after slowing or stopping the blood pump. Late (>3 min) • Completed within 30-60 minutes due to flow-volume disequilibrium.

  23. Urea Rebound 65% rebound ( >50% is AR,15%CP,31% D)

  24. Single-Compartment Fixed VolumeSolute Kinetic Mode

  25. Single-Pool vs Double-Pool Single-pool Does not account for urea transfer between fluid compartments With  dialyzer clearance, urea removed from extracellular compartment can exceed transfer from intracellular compartment Urea rebound (30-60 min) So: Dialysis dose will be overestimated if this urea pool is large (underestimated of true V)

  26. Two-Compartment Variable VolumeSolute Kinetic Model

  27. Equilibrated Kt/V • eKt/v is 0.2 units less than single-pool kt/v, but it can be as great 0.6 unit less. • For most patient, urea rebound is nearly complete in 15 minutes after hemodialysis but for minority, it may require up to 50-60 minutes • The degree of rebound is high in small patient • eKt/V= spKt/V - 0.6 x (spKt/V) / t + 0.03 (for arterial access) • eKt/V= spKt/V - 0.47 x (spKt/V) / t + 0.02 (for venous access)

  28. Minimum dialysis dose • SpKt/V > 1.2 US • eKt/V > 1.2 Europe • StdKt/V 2.14

  29. Daugirdas Formula

  30. Daugirdas Formula

  31. Prescribed vs. delivered Kt/V Prescribed Kt/Vis a computerized estimation of what the patients Kt/V would be, based on the prescription • Delivered Kt/V is actual results based on how the patient really dialyzed the day the kinetic labs were drawn

  32. Discrepancies Between Delivered and Prescribed Dialysis Dose Delivered less than the prescribed: • Low blood flow • Inadequate dialyzer performance • Low dialysate flow • Dialysis machine programmed incorrectly • Hemodialysis ended prematurely • The predialysis BUN was drained after initiation of hemodialysis • Access recirculation

  33. Discrepancies Between Delivered and Prescribed Dialysis Dose • Delivered Dose More than the Prescribed: • Postdialysis BUN was drained from venous bloodline • The post dialysis BUN was diluted with saline • Small (V)

  34. Low kt/v

  35. How to improve clearance • Blood flow • Dialysate flow • Dialyzer • Duration • frequency

  36. Blood flow and Clearance

  37. Blood flow and Clearance

  38. Dialysate flow and clearance

  39. The HEMO Study (2002)

  40. The HEMO Study (2002) Standard dose group High dose group SpKt/V 1.7 eKt/V 1.53 URR 75.2 Dialysis T 219 min • SpKt/V 1.3 • eKt/V 1.16 • URR 66.3 • Dialysis T 190 min

  41. The HEMO Study (2002) EKNOYAN et al N Engl j Med .2002;347:2010

  42. Optimal Dialysis Anemia management BP control Good nutrition Dialysis adequacy Fluid and electrolytes hemostasis Adequate solute removal BMD management

  43. Optimal Dialysis Anemia management BP control Good nutrition Dialysis adequacy Kt/v Fluid and electrolytes hemostasis Adequate solute removal BMD management

  44. Filters Efficiency and Flux • Efficiency: ability to achieve large small solute clearance with high blood flows (all filters are high efficiency these days) • Flux: ability to achieve high middle molecule clearance and ultrafiltration rate (determined by the average pore size) Diffusion and Convection • Diffusion: solutes move by diffusion between blocks of fluid separated by the membrane • Convection: solutes move en mass with a block of fluid across the membrane (more effective for moving large molecules)

  45. The HEMO Study (2002) EKNOYAN et al N Engl j Med.2002 ;347:2010

  46. The MPO Study (2009)

  47. Standard Kt/V

  48. Standard Kt/Vwhy Hemo study is negative ?